KEGG   DRUG: Diclofenac etalhyaluronate sodium
Entry
D11020                      Drug                                   

Name
Diclofenac etalhyaluronate sodium (JAN);
Joycle (TN)
Remark
Therapeutic category: 3999
Chemical structure group: DG02959
Product (DG02959): D11020<JP>
Efficacy
Anti-inflammatory, Joint function improving agent
Target
PTGS2 (COX2) [HSA:5743] [KO:K11987]
MMP1 [HSA:4312] [KO:K01388]
  Pathway
hsa05323  Rheumatoid arthritis
Interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D11020  Diclofenac etalhyaluronate sodium (JAN)
Target-based classification of drugs [BR:br08310]
 Enzymes
  Oxidoreductases (EC1)
   Prostaglandin synthase
    PTGS2 (COX2)
     D11020  Diclofenac etalhyaluronate sodium (JAN) <JP>
  Hydrolases (EC3)
   Metallo peptidases
    MMP1
     D11020  Diclofenac etalhyaluronate sodium (JAN) <JP>
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11020
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11020
Other DBs
PubChem: 348350492
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system